Acquired Resistance to Alectinib in ALK-Rearranged Lung Cancer due to ABCC11/MRP8 Overexpression in a Clinically Paired Resistance Model-论文-万方医学网

Acquired Resistance to Alectinib in ALK-Rearranged Lung Cancer due to ABCC11/MRP8 Overexpression in a Clinically Paired Resistance Model

导出原文传递

翻译打印收藏纠错

作者： Funazo, Tomoko ^[1] ; Tsuji, Takahiro ^[2] ; Ozasa, Hiroaki ^[3] ; Furugaki, Koh ; Yoshimura, Yasushi ; Oguri, Tetsuya ; Ajimizu, Hitomi ; Yasuda, Yuto ; Nomizo, Takashi ; Sakamori, Yuichi ; Yoshida, Hironori ; Kim, Young Hak ; Hirai, Toyohiro

作者单位： Kyoto Univ,Kyoto Univ, Grad Sch Med, Dept Resp Med, Kyoto, Japan ^[1] Chugai Pharmaceut,Chugai Pharmaceut, Kamakura Res Labs, Dept Prod Res, Kamakura, Kanagawa, Japan ^[2] Nagoya City Univ,Nagoya City Univ, Sch Med Sci, Dept Educ, Nagoya, Aichi, Japan ^[3]

关键词 MULTIDRUG-RESISTANCE DRUG-RESISTANCE TRANSPORTERS MRP8/ABCC11 CRIZOTINIB INHIBITORS GENE

发布时间 2022-06-23

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除